Long-term Childhood Outcomes for Babies Born at Term Who Were Exposed to Antenatal Corticosteroids

(Abstracted from Am J Obstet Gynecol 2023;228(1):80.e1–80.e6) The use of antenatal corticosteroids (ACSs) is standard practice for women who are at risk of preterm birth to accelerate the development of vital organs, in particular the fetal lungs. Previous research has shown the efficacy of this treatment and its benefits in infants who are born preterm, but there is little research on the effects of ACS on infants who are subsequently born at term.